Oct 27, 2021

Supermarkets will begin selling rapid antigen tests from next week – how much will they cost?

Coles rapid antigen tests

Rapid antigen tests are nasal tests that allow people to test themselves for COVID-19 at home. The turnaround time for results is 15 minutes.

Anyone who returns a positive rapid antigen test result must present for a PCR test at a GP clinic, pharmacy or testing centre, which will then detect the genetic material of the virus.

Coles will sell Hough Pharma brand nasal tests, which are manufactured in China, in 700 Coles stores around the country.

Tests will be sold in packs of two or five in store, and will also be available to online shoppers.

Woolworths will make tests available initially only in states where there are outbreaks, including the ACT, NSW and Victoria.

Eight rapid antigen tests have now been approved by the Therapeutic Goods Administration (TGA).

Professor Mary-Louise McLaws, Professor of Epidemiology at the University of New South Wales and advisor to the WHO (World Health Organisation), told HelloCare introduction of the tests has been somewhat delayed in Australia, but they will provide an important layer of defence against COVID-19.

Rapid antigen tests can accurately help you identify that you do not have the infection to go to work safely, but also to go and visit an elderly person, she said.

Where there are high levels of the virus circulating in the community, rapid antigen testing can be used to help prevent visitors from bringing the virus into aged care homes, particularly before residents receive their booster shots, Professor McLaws said. 

Professor McLaws said the most desireable tests are those that have the “best ability to find you accurately as not having the disease”. 

The first batch of tests were approved in September, with Health Minister Greg Hunt pointing out they are an essential part of Australia’s reopening plan.

The kits are expected to cost between $10 and $30.

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement
Advertisement
Advertisement

Public “shocked” by staffing gaps in aged care. It took a pandemic for them to notice

Media reports slamming aged care facilities for having only one nurse on duty for more than 100 residents ignore an important fact: this is not unusual in aged care. In fact, it’s the norm. It has been well established by the Royal Commission into Aged Care Quality and Safety, and several inquiries before it, that... Read More

Why do antibodies fade after a COVID-19 infection, and will the same thing happen with vaccines?

The speed with which the scientific and medical communities have developed and tested these new vaccines has been extraordinary. However, this short timescale leaves us with some outstanding questions. Key among these is how long the protection we receive from vaccination, or indeed from infection with the virus itself, will last. We know, for example, that antibody levels drop quite quickly following a COVID-19 infection. Read More

Could the AstraZeneca vaccine cause Guillain-Barré syndrome?

The Therapeutic Goods Administration (TGA) recently revealed there have been six reports of Guillain-Barré syndrome in Australia following the AstraZeneca COVID vaccine. Read More
Advertisement